Colorectal cancer
Conditions
Interventions
Experimental group:Lidocaine will be infused intravenously, 1.5mg/kg for a single injection, and the continuous infusion volume will be 2mg / kg / h until the end of the operation
Control group:Saline
Sponsors
Fujian provincial hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. American Society of Anesthesiologists (ASA) grade I to ?; 2. Age > 18 years of age
Exclusion criteria
Exclusion criteria: 1. Severe arrhythmia; 2. Chronic opioid history; 3. Liver dysfunction; 4. Epilepsy and other diseases that may affect the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of recovery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative acute pain score;Recovery of gastrointestinal function;Nausea, vomiting and other adverse reactions;Emergence time;Postoperative cumulative opioid consumption; | — |
Countries
China
Contacts
Public ContactYao Yusheng
Fujian Medical University
Outcome results
None listed